Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04631133
Other study ID # DHF-111-PMCF1
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date April 17, 2019
Est. completion date December 31, 2028

Study information

Verified date July 2022
Source BACKBONE
Contact Aurélie Affret
Phone 0033686114973
Email aat@backbone.pro
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The study is a post-market surveillance study of the Lumbar Implant for Stiffness Augmentation (LISA), a medical device, which is used to treat low-back pain that accompanies degenerative lesions of grades II, III, and IV (Pfirrmann MRI classification). "Post-market" means the device (i.e. the LISA implant) being used in this study has already obtained CE certification and is commercially available for use in the European market. The LISA device consists of 3 components: A PEEK interspinous spacer, a polyester band, and a titanium blocker. The spacer is positioned between two adjacent spinous processes, the band is belted around the spinous processes and through the spacer, and the blocker is used to lock the band inside the spacer. Medical Device manufacturers conduct "post-market" clinical studies in order to continuously evaluate the product scientifically and to comply with legal and ethical obligations. With these studies, the long-term safety as well as performance of their medical devices are assessed. This study, which is initiated and sponsored by BACKBONE (LISA designer, developer, manufacturer and marketer), aims to evaluate the long-term safety and performance of the LISA implant for the treatment of lumbar degenerative disease and to evaluate the treatment.


Recruitment information / eligibility

Status Recruiting
Enrollment 136
Est. completion date December 31, 2028
Est. primary completion date December 31, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Skeletally mature patients Patient =18 years of age - Patients with low-back pain caused by degenerative lesions of grade II, III and IV (Pfirrmann MRI classification) - Failed conservative treatment for low back pain conducted for at least 6 months Exclusion Criteria: - Stage V degenerative disk lesions in Pfirrmann's MRI classification - Spondylolisthesis - Osteoporosis - Non-specific back pain - Modic 2 and Modic 3 changes - L5/S1 segments affected - Local or general infections that may compromise the surgical goals - Major local inflammatory phenomena - Pregnant and lactating Women - Immunosuppressive diseases - Bone immaturity - Severe mental illnesses - Bone metabolism diseases that may compromise the mechanical support expected from this type of implant - Patient with worker's compensation, under litigation or on disability benefits - Excessive physical activities - Patients deprived of their liberty in accordance with respective national regulations - Protected patients or patients not in a position to declare his or her consent in accordance with respective national regulations

Study Design


Intervention

Device:
Lumbar Implant for Stiffness Augmentation (LISA)
The LISA Posterior Dynamic Stabilization System is intended to treat low-back pain that accompanies degenerative lesions of grade II, III and IV (Pfirrmann MRI classification).

Locations

Country Name City State
Denmark Elective Surgery Center, Silkeborg Regional Hospital Silkeborg
France Pellegrin University Hospital Center Bordeaux
France Saint-Charles Clinic Lyon
France Pitié-Salpêtrière University Hospital Center Paris
Germany Asklepios Stadtklinik, Bad Wildungen Bad Wildungen

Sponsors (1)

Lead Sponsor Collaborator
BACKBONE

Countries where clinical trial is conducted

Denmark,  France,  Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary LISA implant survival rate 2 years after surgery defined as successful LISA implantation without reoperation, revision, or removal/ ODI change between pre-operative assessment and 2 years follow-up (FU)/ 1ary endpoint will also be evaluated at 1-year FU 24-months post surgery; 12-months post surgery
Secondary LISA implant survival rate defined as successful LISA implantation without reoperation, revision, or removal 3-months post surgery; 6-months post surgery; 48-months post surgery; 72-months post surgery
Secondary Duration of the surgery Perioperative
Secondary Duration of the implant placement Perioperative
Secondary Amount of blood loss Perioperative
Secondary Scoring of the surgical technique assessed by a 14-items question 14 steps of the surgical technique are rated from 0 to 7; 0 being considered as very easy and 7 being considered as very difficult Perioperative
Secondary Number of hospitalization days 3-months post surgery
Secondary Time to return to normal activity (working) depending on the patient's profession (blue collar, white collar) 3-months post surgery
Secondary Number of patients with reoperations/ revision or removal at the operative level or on adjacent levels relating to the device and not the pathology/ implant breakage (polyester band rupture) 3-months post surgery; 6-months post surgery; 12-months post surgery; 24-months post surgery; 48-months post surgery; 72-months post surgery
Secondary Number of patients with migration or rupture of any implant component (Polyester band loose)/ major unanticipated device related complications/ post-operative scapular pain/ recurrence of the initial symptoms/ degeneration of the adjacent segments 3-months post surgery; 6-months post surgery; 12-months post surgery; 24-months post surgery; 48-months post surgery; 72-months post surgery
Secondary Number of patients with superficial infection/ dural injury/ bone fracture or bone erosion anywhere implant is in contact with the anatomy/ Any other procedure or device related adverse events 3-months post surgery; 6-months post surgery; 12-months post surgery; 24-months post surgery; 48-months post surgery; 72-months post surgery
Secondary Oswestry Disability Index (ODI) to assess limitations of various activities of daily living. Pre-operative
Secondary Change from baseline in Oswestry Disability Index at 3 months Oswestry Disability Index (ODI) is used to assess limitations of various activities of daily living. 3-months post surgery
Secondary Change from baseline in Oswestry Disability Index at 6 months Oswestry Disability Index (ODI) is used to assess limitations of various activities of daily living. 6-months post surgery
Secondary Change from baseline in Oswestry Disability Index at 48 months Oswestry Disability Index (ODI) is used to assess limitations of various activities of daily living. 48-months post surgery
Secondary Change from baseline in Oswestry Disability Index at 72 months Oswestry Disability Index (ODI) is used to assess limitations of various activities of daily living. 72-months post surgery
Secondary Visual Analogue Scale (VAS) to assess back pain Patients rate their back pain from 0 to 10, "0" meaning "No pain at all" and "10" meaning "the worst pain ever possible" Pre-operative
Secondary Change from baseline in Visual Analogue Scale (VAS) for back pain at 3 months 3-months post surgery
Secondary Change from baseline in Visual Analogue Scale (VAS) for back pain at 6 months 6-months post surgery
Secondary Change from baseline in Visual Analogue Scale (VAS) for back pain at 12 months 12-months post surgery
Secondary Change from baseline in Visual Analogue Scale (VAS) for back pain at 24 months 24-months post surgery
Secondary Change from baseline in Visual Analogue Scale (VAS) for back pain at 48 months 48-months post surgery
Secondary Change from baseline in Visual Analogue Scale (VAS) for back pain at 72 months 72-months post surgery
Secondary Visual Analogue Scale (VAS) to assess right leg pain Patients rate their right leg pain from 0 to 10, "0" meaning "No pain at all" and "10" meaning "the worst pain ever possible" Pre-operative
Secondary Change from baseline in Visual Analogue Scale (VAS) for right leg pain at 3 months 3-months post surgery
Secondary Change from baseline in Visual Analogue Scale (VAS) for right leg pain at 6 months 6-months post surgery
Secondary Change from baseline in Visual Analogue Scale (VAS) for right leg pain at 12 months 12-months post surgery
Secondary Change from baseline in Visual Analogue Scale (VAS) for right leg pain at 24 months 24-months post surgery
Secondary Change from baseline in Visual Analogue Scale (VAS) for right leg pain at 48 months 48-months post surgery
Secondary Change from baseline in Visual Analogue Scale (VAS) for right leg pain at 72 months 72-months post surgery
Secondary Visual Analogue Scale (VAS) to assess left leg pain Patients rate their left leg pain from 0 to 10, "0" meaning "No pain at all" and "10" meaning "the worst pain ever possible" Pre-operative
Secondary Change from baseline in Visual Analogue Scale (VAS) for left leg pain at 3 months 3-months post-surgery
Secondary Change from baseline in Visual Analogue Scale (VAS) for left leg pain at 6 months 6-months post-surgery
Secondary Change from baseline in Visual Analogue Scale (VAS) for left leg pain at 12 months 12-months post-surgery
Secondary Change from baseline in Visual Analogue Scale (VAS) for left leg pain at 24 months 24-months post-surgery
Secondary Change from baseline in Visual Analogue Scale (VAS) for left leg pain at 48 months 48-months post-surgery
Secondary Change from baseline in Visual Analogue Scale (VAS) for left leg pain at 72 months 72-months post-surgery
Secondary Patient satisfaction with treatment assessed by a 4-items question Patients rate their satisfaction with treatment choosing one of the following options: Very satisfied/Somewhat satisfied/Somewhat dissatisfied/Very Dissatisfied 3-months post surgery; 6-months post surgery; 12-months post surgery; 24-months post surgery; 48-months post surgery; 72-months post surgery
Secondary Patient's recommendation for treatment assessed by a 4-items question Patient rate wether they would recommend the same treatment to a friend with the same condition, choosing one of the following options: Definitely YES/Probably YES/ Probably NO/ Definitely NOT 3-months post surgery; 6-months post surgery; 12-months post surgery; 24-months post surgery; 48-months post surgery; 72-months post surgery
Secondary Patient's opinion related to the treatment assessed by a 6-items question Patient rate how effective was the treatment in eliminating the symptoms choosing one of the following options: "very effective, relieved all the symptoms", "moderately effective", "somewhat effective", "somewhat ineffective", "moderately ineffective", "very ineffective, did not relieve or lessen the symptoms" 3-months post surgery; 6-months post surgery; 12-months post surgery; 24-months post surgery; 48-months post surgery; 72-months post surgery
Secondary Surgeon surgery outcome assessed by a 4-items question Surgeons rate the result of the surgery, choosing one of the following options: Excellent; Good; Fair; Poor 3-months post surgery; 6-months post surgery; 12-months post surgery; 24-months post surgery; 48-months post surgery; 72-months post surgery
Secondary Segmental joints condition assessed thanks to radiological results (if available) Pre-operative
Secondary Change from baseline in segmental joints condition at 3-months Segmental joints condition are assessed thanks to radiological results (if available) 3-months post surgery
Secondary Change from baseline in segmental joints condition at 6-months Segmental joints condition are assessed thanks to radiological results (if available) 6-months post surgery
Secondary Change from baseline in segmental joints condition at 12-months Segmental joints condition are assessed thanks to radiological results (if available) 12-months post surgery
Secondary Change from baseline in segmental joints condition at 24-months Segmental joints condition are assessed thanks to radiological results (if available) 24-months post surgery
Secondary Change from baseline in segmental joints condition at 48-months Segmental joints condition are assessed thanks to radiological results (if available) 48-months post surgery
Secondary Change from baseline in segmental joints condition at 72-months Segmental joints condition are assessed thanks to radiological results (if available) 72-months post surgery
Secondary Narrowness of the spinal canal assessed thanks to radiological results (if available) Pre-operative
Secondary Change from baseline in narrowness of the spinal canal at 3 months Narrowness of the spinal canal is assessed thanks to radiological results (if available) 3-months post surgery
Secondary Change from baseline in narrowness of the spinal canal at 6 months Narrowness of the spinal canal is assessed thanks to radiological results (if available) 6-months post surgery
Secondary Change from baseline in narrowness of the spinal canal at 12 months Narrowness of the spinal canal is assessed thanks to radiological results (if available) 12-months post surgery
Secondary Change from baseline in narrowness of the spinal canal at 24 months Narrowness of the spinal canal is assessed thanks to radiological results (if available) 24-months post surgery
Secondary Change from baseline in narrowness of the spinal canal at 48 months Narrowness of the spinal canal is assessed thanks to radiological results (if available) 48-months post surgery
Secondary Change from baseline in narrowness of the spinal canal at 72 months Narrowness of the spinal canal is assessed thanks to radiological results (if available) 72-months post surgery
Secondary Foraminal compression assessed thanks to radiological results (if available) Pre-operative
Secondary Change from baseline in foraminal compression at 3 months Foraminal compression is assessed thanks to radiological results (if available) 3-months post-surgery
Secondary Change from baseline in foraminal compression at 6 months Foraminal compression is assessed thanks to radiological results (if available) 6-months post-surgery
Secondary Change from baseline in foraminal compression at 12 months Foraminal compression is assessed thanks to radiological results (if available) 12-months post-surgery
Secondary Change from baseline in foraminal compression at 24 months Foraminal compression is assessed thanks to radiological results (if available) 24-months post-surgery
Secondary Change from baseline in foraminal compression at 48 months Foraminal compression is assessed thanks to radiological results (if available) 48-months post-surgery
Secondary Change from baseline in foraminal compression at 72 months Foraminal compression is assessed thanks to radiological results (if available) 72-months post-surgery
See also
  Status Clinical Trial Phase
Recruiting NCT04848376 - Post-Market Clinical Follow-up Study of A-SPINE's Products
Active, not recruiting NCT05114135 - TLIF Osteo3 ZP Putty Study (Also Known as the TOP Fusion Study) N/A
Suspended NCT04735185 - Stem Cells vs. Steroids for Discogenic Back Pain N/A
Withdrawn NCT03223701 - Efficacy of Using Solum IV and BMC With GFC in TLIF Phase 4
Completed NCT04057235 - Retrospective Review of Integrity Implants FlareHawk® for Lumbar Fusion
Not yet recruiting NCT06000319 - Natural Matrix Protein™ (NMP™) Fibers in Cervical and Lumbar Interbody Fusion
Active, not recruiting NCT02969616 - Trinity Elite in Lumbar Fusion
Completed NCT02558621 - New Robotic Assistance System for Spinal Fusion Surgery N/A
Completed NCT02104167 - Retrospective/Prospective Data Collection on the LDR ROIC Interbody Fusion Device With VerteBRIDGE Plating
Terminated NCT00974623 - Bone Graft Materials Observational Registry N/A
Completed NCT00965380 - Trinity Evolution in Posterior or Transforaminal Lumbar Interbody Fusion (PLIF/TLIF)
Completed NCT00996073 - Safety and Preliminary Efficacy Study of NeoFuse in Subjects Requiring Lumbar Interbody Fusion Phase 2
Completed NCT00758719 - Evaluate Effectiveness of the Biomet Lumbar Spinal Fusion System
Completed NCT00165893 - Comparison of IDD Therapy and Non-surgical Treatment for Low Back Pain Caused by Degenerative Disc Disease Phase 4
Terminated NCT01494493 - Pivotal Study of rhBMP-2/ACS/Allograft Bone Dowel for Anterior Lumbar Interbody Fusion in Patients With Symptomatic Degenerative Disc Disease N/A
Recruiting NCT04727385 - Intervertebral DXM Gel Injection in Adults With Painful Lumbar Degenerative Disc Disease N/A
Completed NCT04849429 - Intra-discal Injection of Platelet-rich Plasma (PRP) Enriched With Exosomes in Chronic Low Back Pain Phase 1
Recruiting NCT04469387 - Preventive Effect of Limited Decompression on Adjacent Segment Following Posterior Lumbar Interbody Fusion N/A
Recruiting NCT04056520 - Clinical and Radiological Outcomes of Posterior Cervical Fusion With Medtronic Infinity Occipitocervical-Upper Thoracic (OCT) System
Completed NCT04119466 - Stabilizing Training in Degenerative Disc Disease N/A